What is Aida Pharmaceuticals, Inc. (AIDA) stock price today?

Aida Pharmaceuticals, Inc. (AIDA) is currently trading at $0.00.

What is AIDA P/E ratio?

Aida Pharmaceuticals, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AIDA return on equity (ROE)?

Aida Pharmaceuticals, Inc.'s return on equity (ROE) is -1.79%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Aida Pharmaceuticals, Inc.'s market cap?

Aida Pharmaceuticals, Inc. has a market capitalization of $8101.

OTC · Drug Manufacturers - Specialty & Generic

Aida Pharmaceuticals, Inc. (AIDA) Stock

$0.00 OTC: AIDA Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$8101
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.31
EPS (TTM)	$0.00
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-1.79%
ROA	6.62%
ROCE	22.82%
Gross Margin	55.06%
Operating Margin	21.30%
Net Margin	-5.38%
Debt/Equity	2.37
Current Ratio	0.73

Annual Financials (USD)

Metric	2004	2005	2006	2007
Revenue	$16.0M	$25.0M	$30.0M	$29.0M
Operating Profit	$3.0M	$2.0M	$4.0M	$5.0M
Net Profit	$2.0M	$1.0M	$1.0M	$3.0M
EPS	$0.07	$0.06	$0.06	$0.10
Op Margin	18.3%	8.6%	13.3%	18.6%

Balance Sheet (USD)

Metric	2004	2005	2006	2007
Total Assets	—	$43.0M	$54.0M	$63.0M
Total Liabilities	—	$32.0M	$38.0M	$42.0M
Cash	—	$3.0M	$6.0M	$8.0M
Borrowings	$0	$25.0M	$30.0M	$33.0M

Cash Flow (USD)

Metric	2004	2005	2006	2007
Operating Cash Flow	—	$6.0M	$3.0M	$8.0M
Investing Cash Flow	—	$-5.0M	$-7.0M	$-15.0M
Financing Cash Flow	—	$-2.0M	$0	$1.0M
Net Cash Flow	—	$0	$3.0M	$2.0M
Free Cash Flow	$0	$5.0M	$0	$5.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	3.41
FCF Yield	58985.69%
Quick Ratio	0.83
Interest Coverage	2.69
Return 1Y	—
Return 3Y	—
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.

Aida Pharmaceuticals, Inc. (AIDA) stock trades at $0.00 with a market capitalization of $8101. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.31. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Aida Pharmaceuticals, Inc. generates a return on equity (ROE) of -1.79%, return on capital employed of 22.82%, an operating margin of 21.30%, a net profit margin of -5.38%.

Official website: www.aidapharma.com